Brief: GeNeuro Partners With Northwestern University Enter On Research On HERV-W ENV In Long-Haul COVID
Sept 24 (Reuters) - Geneuro SA GNRO.PA :
* GENEURO AND NORTHWESTERN UNIVERSITY ENTER INTO A RESEARCH
COLLABORATION ON HERV-W ENV IN LONG-HAUL COVID
* RESEARCH AIMS TO CONFIRM EVIDENCE OF EXPRESSION OF HUMAN
ENDOGENOUS RETROVIRUS W ENVELOPE PROTEIN (HERV-W ENV OR W-ENV)
IN LONG-HAUL COVID PATIENTS
* RESEARCH AIMS TO IDENTIFY AFFECTED PATIENTS WHO MAY
BENEFIT FROM
A TREATMENT WITH GENEURO'S TEMELIMAB
Source text for Eikon: ID:nBwJbxZ5a
Further company coverage: GNRO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Geneuro SA
See all newsBrief: Geneuro SA Postpones Publication Of Half-Yearly Financial Report
Brief: Geneuro SA Announces Extension Of Its Definitive Debt-Restructuring Moratorium
Brief: Geneuro SA Announces The Opening Of Receivership Proceedings For Its French Subsidiary Geneuro Innovation Sas
Brief: Geneuro Confirms Top-Line Results In Its Post-Covid Trial By End-June
Brief: Geneuro announces EUR 5 Mln private placement